SSG
NUVB icon

Summit Securities Group’s Nuvation Bio NUVB Stock Holding History

Summit Securities Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,215
Closed -$30K – 713
2024
Q1 		$30K Buy
+8,215
New +$15.8K ﹤0.01% 285

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Summit Securities Group's NUVB Position: Q2 2024 in Review

Summit Securities Group sold out of Nuvation Bio (NUVB) in Q2 2024, closing a stake of 8,215 shares — an estimated $30K sold.

Summit Securities Group first reported a position in NUVB in Q1 2024 and held it in 1 quarter. The position peaked at $30K in Q1 2024. 148 funds tracked by Wall St. Rank hold NUVB as of Q2 2024.

  • Summit Securities Group reported no remaining Nuvation Bio position as of Q2 2024 after selling out during the quarter.
  • Summit Securities Group sold 8,215 Nuvation Bio shares in Q2 2024, an estimated $30K.
  • Summit Securities Group first reported a position in Nuvation Bio in Q1 2024 and held it in 1 quarter.
  • Summit Securities Group's Nuvation Bio position peaked at $30K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2024.

Based on Summit Securities Group's 13F filing for Q2 2024, filed 26 Jul 2024.